Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each myosin...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abnormal position of a GNAS methylation regulatory element causes autosomal dominant pseudohypoparathyroidism type 1B (PHP1B).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Circulating MYOM3 fragments reflect disease severity and therapeutic efficacy in tubular aggregate myopathy and Stormorken syndrome.

Human molecular genetics·2026
Same author

Long-term treatment outcomes of immune checkpoint inhibitor-related neuropathies: a French multicenter cohort study.

Scientific reports·2026
Same author

Decoding splicing variants in high-throughput sequencing: a functional validation approach integrating deep learning tools.

European journal of human genetics : EJHG·2026
Same author

Exploring the impact of myotonia on daily functioning in myotonic dystrophy: a patient-reported survey.

BMC neurology·2026
Same author

Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.

Annales d'endocrinologie·2026

Related Experiment Video

Updated: Jul 4, 2026

Skeletal Muscle Gender Dimorphism from Proteomics
09:29

Skeletal Muscle Gender Dimorphism from Proteomics

Published on: December 14, 2011

Phenotype-specific muscle proteomic profiling in titinopathies.

Aurélien Perrin1,2, Marie-Rocio Casenave-Camgaston3,4, Baptiste Rabillard4

  • 1Laboratoire de Génétique Moléculaire, Centre Hospitalier Universitaire de Montpellier, 34093, Montpellier, France. aurelien.perrin@ext.inserm.fr.

Acta Neuropathologica Communications
|July 3, 2026
PubMed
Summary

Titinopathies, complex neuromuscular disorders, show distinct protein changes in arthrogryposis and myofibrillar myopathy phenotypes. This research identifies specific deregulations, aiding in biomarker discovery and targeted therapies for these conditions.

Keywords:
Mass spectrometryMyopathiesProteomicTitinopathies

More Related Videos

Tissue Triage and Freezing for Models of Skeletal Muscle Disease
05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis
07:44

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis

Published on: June 8, 2020

Related Experiment Videos

Last Updated: Jul 4, 2026

Skeletal Muscle Gender Dimorphism from Proteomics
09:29

Skeletal Muscle Gender Dimorphism from Proteomics

Published on: December 14, 2011

Tissue Triage and Freezing for Models of Skeletal Muscle Disease
05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis
07:44

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis

Published on: June 8, 2020

Area of Science:

  • Neuromuscular Disorders
  • Molecular Biology
  • Genetics

Background:

  • Titinopathies are complex neuromuscular disorders with diverse phenotypes, stemming from the large size of the titin gene and protein.
  • Understanding protein alterations is crucial for characterizing titinopathies, particularly arthrogryposis and myofibrillar myopathy phenotypes.

Purpose of the Study:

  • To analyze and compare protein deregulations in French patients with arthrogryposis and myofibrillar myopathy phenotypes of titinopathies.
  • To identify phenotype-specific protein changes and disrupted signaling networks in titinopathies.

Main Methods:

  • Muscle biopsies from patients with titinopathies (arthrogryposis and myofibrillar myopathy phenotypes) and control individuals were analyzed.
  • Mass spectrometry was employed to quantify protein level changes in the patient cohorts.

Main Results:

  • Specific protein deregulations were identified for each phenotype: fibrosis and actomyosin complex involvement in arthrogryposis, and cytoskeleton-related muscle contraction system impact in myofibrillar myopathy.
  • Quantitative proteomic analysis revealed disrupted signaling networks underlying titinopathies.

Conclusions:

  • The study provides a detailed characterization of protein alterations in distinct titinopathy phenotypes.
  • Findings support the identification of phenotype-specific biomarkers and may guide the development of targeted therapies for titinopathies.